Fig. 1. Study overview and mutation characteristics of BilIN-related GBC.
a Overall study design. b The TMB distribution of BilIN-related gallbladder carcinoma (GBC) in the context of stage-I samples from 16 TCGA cancer types. c Relative contributions of different mutational signatures (annotated by etiology factors) in GBC and 16 TCGA cancer types. b, c GBC is highlighted in the red box. READ: rectum adenocarcinoma; THCA: thyroid carcinoma; TGCT: testicular germ cell tumors; KICH: kidney chromophobe; BRCA: breast invasive carcinoma; CHOL: cholangiocarcinoma; PAAD: pancreatic adenocarcinoma; KIRC: kidney renal cell carcinoma; KIRP: kidney renal papillary cell carcinoma; LIHC: liver hepatocellular carcinoma; HNSC: head and neck squamous cell carcinoma; ESCA: esophageal carcinoma; COAD: colon adenocarcinoma; STAD: stomach adenocarcinoma; LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma.